International Stem Cell CORP
ISCO· OTC
ISCOInternational Stem Cell CORP
Released Aug 13, 2021, after the close
10-Q filed Aug 13, 2021, 44 days after period end · 0001564590-21-044294
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q2 2021 | Q2 2020 | Q2 2019 | Q2 2018 |
|---|---|---|---|---|
| Revenue | $1.83M | $1.81M | $2.32M | $3.04M |
| Net Income | $216.00K | -$1.09M | -$648.00K | -$394.00K |
| EPS Diluted | $0.03 |
International Stem Cell CORP · CIK 1355790 · Engraved from SEC EDGAR
| -$0.14 |
| -$0.09 |
| -$0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
